Drug record discrepancies in an outpatient electronic medical record: Frequency, type, and potential impact on patient care at a hemodialysis center

Pharmacotherapy

Volumn 23, Issue 2, 2003, Pages 231-239

  Manley, Harold J ^a,b   Drayer, Debra K ^a,b   McClaran, Marcy ^b   Bender, Walter ^b,c   Muther, Richard S ^b,c  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b Dialysis Clinic Incorporated   (United States)

^c Infectious Disease Associates of Kansas City   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTICOAGULANT AGENT; ANTIDIARRHEAL AGENT; ANTIHISTAMINIC AGENT; ANTIINFECTIVE AGENT; ANTIPRURITIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIOVASCULAR AGENT; ERYTHROPOIETIN; GASTROINTESTINAL AGENT; HISTAMINE H2 RECEPTOR AGONIST; HORMONE; HYPOCHOLESTEROLEMIC AGENT; INSULIN; IRON; LAXATIVE; MACROLIDE; NARCOTIC ANALGESIC AGENT; NEUROLEPTIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PHOSPHATE BINDING AGENT; PROTON PUMP INHIBITOR; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR; THIAZOLIDINE DERIVATIVE; TOPICAL AGENT; VITAMIN; VITAMIN D DERIVATIVE;

ACCURACY; ADULT; ADVERSE DRUG REACTION; AGE; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DRUG DOSE REGIMEN; DRUG SURVEILLANCE PROGRAM; DRUG UTILIZATION; ELECTRONIC MEDICAL RECORD; ERROR; EVALUATION; FEMALE; HEMODIALYSIS; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; OUTPATIENT DEPARTMENT; PATIENT CARE; PATIENT INFORMATION; PHARMACIST; PROSPECTIVE STUDY; RISK ASSESSMENT;

AMBULATORY CARE; DRUG INTERACTIONS; DRUG UTILIZATION REVIEW; FEMALE; HUMANS; INTERVIEWS; MALE; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MEDICATION ERRORS; MIDDLE AGED; MISSOURI; OUTCOME ASSESSMENT (HEALTH CARE); PHARMACEUTICAL PREPARATIONS; PROSPECTIVE STUDIES; RENAL DIALYSIS; SELF ADMINISTRATION;

EID: 0037320347     PISSN: 02770008     EISSN: None     Source Type: Journal    
DOI: 10.1592/phco.23.2.231.32079     Document Type: Article

References (36)

1. Kohn LT, Corrigan JM, Donaldson MS, eds. To err is human: building a safer health system. Washington, DC: National Academy Press, 1999,
2. Ernst FR, Grizzle AJ. Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc 2001;41:192-9.
3. Nelson KM, Talbert RL. Drug-related hospital admissions. Pharmacotherapy 1996;16:701-7.
4. Ebbesen J, Buajordet I, Erikssen J, et al. Drug-related deaths in a department of internal medicine. Arch Intern Med 2001;161:2317-23.
5. Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA 1998;279:1200-5.
6. Strand LM, Morley PC, Cipolle RJ. Drug-related problems: their structure and function. DICP Ann Pharmacother 1990;24:1093-7.
7. Bates DW. Using information technology to reduce rates of medication errors in hospitals. BMJ 2000;320:788-91.
8. Kaushal R, Barker KN, Bates DW. How can information technology improve patient safety and reduce medication errors in children's health care? Arch Pediatr Adolesc Med 2001;155:1002-7.
9. Orser B. Reducing medication errors. Can Med Assoc J 2000;162:1150-1.
10. Ernst ME, Brown GL, Klepser TB, Kelly MW. Medication discrepancies in an outpatient electronic medical record. Am J Health-Syst Pharm 2001;58:2072-5.
11. National Institutes of Health. United States renal data systems (USRDS) 1999 annual data report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes, Digestive, and Kidney Diseases, 1999.
12. Manley HJ, McClaran ML, Franklin B. Medication costs and potential adverse drug event rate in ESRD outpatients: a pilot study [abstr]. Pharmacotherapy 2001;21:1278.
13. Manley HJ, Bailie GR, Grabe DW. National database information: utility for an individual hemodialysis center. Am J Health-Syst Pharm 2000;57:902-6.
14. Grabe DW, Low CL, Bailie GR, Eisele G. Evaluation of drugrelated problems in an outpatient hemodialysis unit and the impact of a clinical pharmacist. Clin Nephrol 1997;47:117-21.
15. Kaplan B, Mason NA, Shimp LA, Ascione FJ. Chronic hemodialysis patients. I. Characterization and drug-related problems. Ann Pharmacother 1994;28:316-19.
16. Kaplan B, Shimp LA, Mason NA, Ascione FJ. Chronic hemodialysis patients. II. Reducing drug-related problems through application of the focused drug therapy review program. Ann Pharmacother 1994;28:320-4.
17. Stoutakis VA, Acchiardo SR, Martinez DR, Lorisch D, Wood GC. Role-effectiveness of the pharmacist in the treatment of hemodialysis patients. Am J Hosp Pharm 1978;35:62-5.
18. Tang I, Vrahnos D, Hatoum H, Lau A. Effectiveness of clinical pharmacist interventions in a hemodialysis unit. Clin Ther 1993;15:459-64.
19. National Institutes of Health. United States renal data systems (USRDS) 1998 annual data report. Bethesda, MD: National Institutes of Health, National Institute of Diabetes, Digestive, and Kidney Diseases, 1998.
20. Koecheler JA, Abramowitz PW, Swim SE, Daniels CE. Indicators for the selection of ambulatory patients who warrant pharmacist monitoring. Am J Hosp Pharm 1989;46:729-32.
21. Cullen DJ, Sweitzer BJ, Bates DW, Burdick E, Edmondson A, Leape LL. Preventable adverse drug events in hospitalized patients: a comparative study of intensive care units and general care units. Crit Care Med 1997;25:1289-97.
22. Bedell SF, Jabbour S, Goldberg R, et al. Discrepancies in the use of medications: their extent and predictors in an outpatient practice. Arch Intern Med 2000;160:2129-34.
23. Wagner MM, Hogan WR. The accuracy of medication data in an outpatient electronic medical record. J Am Med Inform Assoc 1996;3:61-8.
24. Bleyer AJ, Hylander B, Sudo H, et al. An international study of patient compliance with hemodialysis. JAMA 1999;281:1211-13.
25. Long JM, Kee CC, Graham MV, Saethang TB, Dames FD. Medication compliance and the older hemodialysis patient. Am Nephrol Nurse Assoc J 1998;25:43-9.
26. Curtin RB, Svarstad BL, Keller TH. Hemodialysis patients' noncompliance with oral medications. Am Nephrol Nurse Assoc J 1999;26:307-16.
27. Bander SJ, Walters BA. Hemodialysis morbidity and mortality: links to patient non-compliance. Curr Opin Nephrol Hypertens 1998;7:649-53.
28. Leggat JE, Orzol SM, Hulbert-Shearon TE, et al. Noncompliance in hemodialysis: predictors and survival analysis. Am J Kidney Dis 1998;32:139-45.
29. Kutner NG, Zhang R, McClellan WM, Cole SA. Psychosocial predictors of non-compliance in haemodialysis and peritoneal dialysis patients. Nephrol Dial Transplant 2002;17:93-9.
30. Shah N, Dahl NV, Kapoian T, Sherman RA, Walker JA. The nephrologist as a primary care provider for the hemodialysis patient [abstr]. J Am Soc Nephrol 2001;12:244A.
31. Bender FH, Holley JL. Most nephrologists are primary care providers for chronic dialysis patients: results of a national survey. Am J Kidney Dis 1996;28:67-71.
32. Pincus T, Sokka T, Stein CM, on behalf of the American College of Physicians-American Society of Internal Medicine Health and Public Policy Committee. Pharmacist scope of practice: position paper. Ann Intern Med 2002;136:79-85.
33. American College of Clinical Pharmacy. Today's pharmacist...the patient's partner in medication management. Available from http://www.accp.com/position/paper11.pdf. Accessed January 29, 2002.
34. National Institutes of Health. United States renal data systems 2001 annual data report. Bethesda, MD: The National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2001.
35. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm 1990;47:533-43.
36. Manley HJ, Carroll C. The clinical and economic impact of pharmaceutical care in end-stage renal disease patients. Semin Dial 2002;15:45-9.